Are Weight-Loss Drugs Like Gym Memberships? The Answer Is Worth Billions
An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...
The Financial Express10d
Blockbuster weight loss drug Tirzepatide coming to India soon: Benefits, weight loss potential, and side effects
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
Insider Monkey11d
Jim Cramer on Eli Lilly and Company (LLY)’s Q4 2024 Performance: ‘Aren’t As Strong As Wall Street Was Hoping’
Beyond GLP-1 drugs, healthcare companies are expanding their portfolios with new cancer therapies ... who can’t diet or ...
Meet ‘Super’ Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
Pharm Exec14d
FDA Approves Eli Lilly’s Omvoh for Crohn Disease
The FDA has approved Eli Lilly’s Omvoh (mirikizumab-mrkz ... According to the company, Omvoh is the first biologic drug in over 15 years to provide the FDA with two-year Phase III efficacy data at ...
Pharmaceutical Technology14d
Lilly gains US FDA approval for Omvoh to treat Crohn’s disease
Visible healing of the intestinal lining was observed in 46% of subjects treated with the therapy. Credit: SewCreamStudio/Shutterstock. Eli Lilly has received ...
Morningstar14d
Eli Lilly Receives FDA Approval for Crohn's Disease Treatment
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.
The Independent15d
Oral Ozempic and a ‘miracle’ pill imitating the keto diet – a new era of weight loss is here
as did Eli Lilly, the maker of Mounjaro. As those developments continue to bubble away in the background, a new market is rapidly expanding. Late last year saw an onslaught of “natural ...